glp 1 hunger GLP-1 Genetics: How Genes Affect Appetite, Semaglutide, and Tirzepatide Response glp 1 hunger Weight Management
Description
taking more than prescribed or escalating too quickly can intensify side effects
Each received a daily subcutaneous injection for one year: half (102) received up to 1.8 mg of liraglutide and half (102) received a placebo
As a dual-action peptide, it targets both GLP-1 and GIP (glucose-dependent insulinotropic polypeptide) receptors, enhancing its efficacy
Graphical Abstract Access this article Similar content being viewed by others Data Availability The dataset analysed in the current study is not publicly available as this is not approved by the participants within the framework of the general informed consent
